Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: mc who wrote (2215)	2/3/1998 10:27:00 PM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Gary McBride, I believe the point of the last stock offering was to put them in a better position to negotiate with big pharma for the Vasomax rights and to assure that they had enough $$ to finish the clinicals if they were unable to secure a partner. They cut off negotiations and began to prepare for the offering. At about the same time, the stock ran up quickly so the proceeds of the offering were much higher than they originally targeted. With lots of cash, they went back to the negotiating - but from a position of strength & closed the deal with SGP. Actually a tremendous achievement - but blunted by the first of Asensio's lying reports released the next day. Asensio had to do something as he had undoubtedly taken a short position & couldn't allow the stock to cliimb on the good news. But all his reports are now exposed for what they really were - an attempt to manipulate the stock price for his own gain. Virtually every one of Asensio's charges are trumped up. IMHO, some of the rational concerns about this stock are: 1- FDA approval -always a concern until obtained - anyone who thinks they won't file an NDA at all is smoking something they shouldn't - and they ARE inhaling. 2- Patents - an application is pending - decision due soon - Zona's attorneys advise a very high probability of issuance but, like FDA approval - NO ONE KNOWS until it happens. 3- The outcome of Pfizer's NDA submission. 4- SGP's ability to compete with PFE 5- Actual market size. There are probably more but these are my biggies. Zona could crash & burn or go through the roof - you pays your money & you takes your chance. Good luck - and try not to listen to the crazies on this thread - there are some honest, smart people here - long & short - you should be able to pick them out.